Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 314

1.

Kras/ADAM17-dependent Jag1-ICD reverse signalling sustains colorectal cancer progression and chemoresistance.

Pelullo M, Nardozza F, Zema S, Quaranta R, Nicoletti C, Besharat ZM, Felli MP, Cerbelli B, d'Amati G, Palermo R, Capalbo C, Talora C, Di Marcotullio L, Giannini G, Checquolo S, Screpanti I, Bellavia D.

Cancer Res. 2019 Sep 10. pii: canres.0145.2019. doi: 10.1158/0008-5472.CAN-19-0145. [Epub ahead of print]

PMID:
31506332
2.

A prospective evaluation of clinical and instrumental features before and after ventriculo-peritoneal shunt in patients with idiopathic Normal pressure hydrocephalus: The Bologna PRO-Hydro study.

Giannini G, Palandri G, Ferrari A, Oppi F, Milletti D, Albini-Riccioli L, Mantovani P, Magnoni S, Chiari L, Cortelli P, Cevoli S; BOLOGNA PRO-HYDRO Study Group.

Parkinsonism Relat Disord. 2019 Jul 18. pii: S1353-8020(19)30311-6. doi: 10.1016/j.parkreldis.2019.07.021. [Epub ahead of print]

PMID:
31358442
3.

ERAP1 promotes Hedgehog-dependent tumorigenesis by controlling USP47-mediated degradation of βTrCP.

Bufalieri F, Infante P, Bernardi F, Caimano M, Romania P, Moretti M, Lospinoso Severini L, Talbot J, Melaiu O, Tanori M, Di Magno L, Bellavia D, Capalbo C, Puget S, De Smaele E, Canettieri G, Guardavaccaro D, Busino L, Peschiaroli A, Pazzaglia S, Giannini G, Melino G, Locatelli F, Gulino A, Ayrault O, Fruci D, Di Marcotullio L.

Nat Commun. 2019 Jul 24;10(1):3304. doi: 10.1038/s41467-019-11093-0.

4.

Evaluation of CYP17A1 and CYP1B1 polymorphisms in male breast cancer risk.

Rizzolo P, Silvestri V, Valentini V, Zelli V, Bucalo A, Zanna I, Bianchi S, Tibiletti MG, Russo A, Varesco L, Tedaldi G, Bonanni B, Azzollini J, Manoukian S, Coppa A, Giannini G, Cortesi L, Viel A, Montagna M, Peterlongo P, Radice P, Palli D, Ottini L.

Endocr Connect. 2019 Jul 1. pii: EC-19-0225.R1. doi: 10.1530/EC-19-0225. [Epub ahead of print]

5.

State and trait anger and its expression in cluster headache compared with migraine: a cross-sectional study.

Rausa M, Cevoli S, Giannini G, Favoni V, Contin SA, Zenesini C, Ballardini D, Cortelli P, Pierangeli G.

Neurol Sci. 2019 Jun 28. doi: 10.1007/s10072-019-03987-0. [Epub ahead of print]

PMID:
31254182
6.

Environmental radiation dosimetry at high southern latitudes with Liulin type instruments.

Zanini A, Vernetto S, Ciancio V, Di Giovan G, Morfino P, Liberatore A, Giannini G, Hubert G.

J Environ Radioact. 2019 Jun 22;208-209:105993. doi: 10.1016/j.jenvrad.2019.105993. [Epub ahead of print]

PMID:
31238239
7.

Synthesis and preliminary in vitro evaluation of DOTA-Tenatumomab conjugates for theranostic applications in tenascin expressing tumors.

Giannini G, Milazzo FM, Battistuzzi G, Rosi A, Anastasi AM, Petronzelli F, Albertoni C, Tei L, Leone L, Salvini L, De Santis R.

Bioorg Med Chem. 2019 Aug 1;27(15):3248-3253. doi: 10.1016/j.bmc.2019.05.047. Epub 2019 May 31.

8.

Suicide and suicide attempts after subthalamic nucleus stimulation in Parkinson disease.

Giannini G, Francois M, Lhommée E, Polosan M, Schmitt E, Fraix V, Castrioto A, Ardouin C, Bichon A, Pollak P, Benabid AL, Seigneuret E, Chabardes S, Wack M, Krack P, Moro E.

Neurology. 2019 Jul 2;93(1):e97-e105. doi: 10.1212/WNL.0000000000007665. Epub 2019 May 17.

PMID:
31101738
9.

Next-generation sequencing of BRCA1 and BRCA2 genes for rapid detection of germline mutations in hereditary breast/ovarian cancer.

Nicolussi A, Belardinilli F, Mahdavian Y, Colicchia V, D'Inzeo S, Petroni M, Zani M, Ferraro S, Valentini V, Ottini L, Giannini G, Capalbo C, Coppa A.

PeerJ. 2019 Apr 22;7:e6661. doi: 10.7717/peerj.6661. eCollection 2019.

10.

Intravascular B-cell lymphoma: case report of a rare cause of pulmonary arterial hypertension.

Share M, Giannini G, Kim S, Singh S.

Eur Heart J Case Rep. 2019 Feb 2;3(1):yty150. doi: 10.1093/ehjcr/yty150. eCollection 2019 Mar.

11.

Revisiting the Cerebrospinal Fluid Biomarker Profile in Idiopathic Normal Pressure Hydrocephalus: The Bologna Pro-Hydro Study.

Abu-Rumeileh S, Giannini G, Polischi B, Albini-Riccioli L, Milletti D, Oppi F, Stanzani-Maserati M, Capellari S, Mantovani P, Palandri G, Cortelli P, Cevoli S, Parchi P.

J Alzheimers Dis. 2019;68(2):723-733. doi: 10.3233/JAD-181012.

PMID:
30883350
12.

Functional analysis finds differences on the muscle transcriptome of pigs fed an n-3 PUFA-enriched diet with or without antioxidant supplementations.

Vitali M, Sirri R, Zappaterra M, Zambonelli P, Giannini G, Lo Fiego DP, Davoli R.

PLoS One. 2019 Feb 20;14(2):e0212449. doi: 10.1371/journal.pone.0212449. eCollection 2019.

13.

A Simplified Genomic Profiling Approach Predicts Outcome in Metastatic Colorectal Cancer.

Capalbo C, Belardinilli F, Raimondo D, Milanetti E, Malapelle U, Pisapia P, Magri V, Prete A, Pecorari S, Colella M, Coppa A, Bonfiglio C, Nicolussi A, Valentini V, Tessitore A, Cardinali B, Petroni M, Infante P, Santoni M, Filetti M, Colicchia V, Paci P, Mezi S, Longo F, Cortesi E, Marchetti P, Troncone G, Bellavia D, Canettieri G, Giannini G.

Cancers (Basel). 2019 Jan 27;11(2). pii: E147. doi: 10.3390/cancers11020147.

14.

Transient Disappearance of RAS Mutant Clones in Plasma: A Counterintuitive Clinical Use of EGFR Inhibitors in RAS Mutant Metastatic Colorectal Cancer.

Raimondi C, Nicolazzo C, Belardinilli F, Loreni F, Gradilone A, Mahdavian Y, Gelibter A, Giannini G, Cortesi E, Gazzaniga P.

Cancers (Basel). 2019 Jan 4;11(1). pii: E42. doi: 10.3390/cancers11010042.

15.

Insight into genetic susceptibility to male breast cancer by multigene panel testing: Results from a multicenter study in Italy.

Rizzolo P, Zelli V, Silvestri V, Valentini V, Zanna I, Bianchi S, Masala G, Spinelli AM, Tibiletti MG, Russo A, Varesco L, Giannini G, Capalbo C, Calistri D, Cortesi L, Viel A, Bonanni B, Azzollini J, Manoukian S, Montagna M, Peterlongo P, Radice P, Palli D, Ottini L.

Int J Cancer. 2019 Jul 15;145(2):390-400. doi: 10.1002/ijc.32106. Epub 2019 Jan 24.

PMID:
30613976
16.

Molecular characterization of metaplastic breast carcinoma via next-generation sequencing.

Zhai J, Giannini G, Ewalt MD, Zhang EY, Invernizzi M, Niland J, Lai LL.

Hum Pathol. 2019 Apr;86:85-92. doi: 10.1016/j.humpath.2018.11.023. Epub 2018 Dec 8.

PMID:
30537493
17.

Stridor-related gray matter alterations in multiple system atrophy: A pilot study.

Testa C, Calandra-Buonaura G, Evangelisti S, Giannini G, Provini F, Ratti S, Cecere A, Talozzi L, Manners DN, Lodi R, Tonon C, Cortelli P.

Parkinsonism Relat Disord. 2019 May;62:226-230. doi: 10.1016/j.parkreldis.2018.11.018. Epub 2018 Nov 17.

PMID:
30509725
18.

Effect of diets supplemented with linseed alone or combined with vitamin E and selenium or with plant extracts, on Longissimus thoracis transcriptome in growing-finishing Italian Large White pigs.

Sirri R, Vitali M, Zambonelli P, Giannini G, Zappaterra M, Lo Fiego DP, Sami D, Davoli R.

J Anim Sci Biotechnol. 2018 Nov 20;9:81. doi: 10.1186/s40104-018-0297-2. eCollection 2018.

19.

Observing movement disorders: best practice proposal in the use of video recording in clinical practice.

Sambati L, Baldelli L, Calandra Buonaura G, Capellari S, Giannini G, Scaglione CLM, Armaroli M, Zoni E, Cortelli P, Martinelli P.

Neurol Sci. 2019 Feb;40(2):333-338. doi: 10.1007/s10072-018-3639-0. Epub 2018 Nov 17.

PMID:
30448965
20.

Novel Symmetrical Benzazolyl Derivatives Endowed with Potent Anti-Heparanase Activity.

Messore A, Madia VN, Pescatori L, Saccoliti F, Tudino V, De Leo A, Bortolami M, De Vita D, Scipione L, Pepi F, Costi R, Rivara S, Scalvini L, Mor M, Ferrara FF, Pavoni E, Roscilli G, Cassinelli G, Milazzo FM, Battistuzzi G, Di Santo R, Giannini G.

J Med Chem. 2018 Dec 13;61(23):10834-10859. doi: 10.1021/acs.jmedchem.8b01497. Epub 2018 Nov 29.

PMID:
30412404
21.

Antibody drug conjugates (ADCs) charged with HDAC inhibitor for targeted epigenetic modulation.

Cini E, Faltoni V, Petricci E, Taddei M, Salvini L, Giannini G, Vesci L, Milazzo FM, Anastasi AM, Battistuzzi G, De Santis R.

Chem Sci. 2018 Jul 3;9(31):6490-6496. doi: 10.1039/c7sc05266a. eCollection 2018 Aug 21.

22.

Growth inhibition of human ovarian carcinoma by a novel AvidinOX-anchored biotinylated camptothecin derivative.

Minenkova O, Vesci L, De Santis R, Santapaola D, Cincinelli R, Musso L, Dallavalle S, Giannini G.

Bioorg Med Chem Lett. 2018 Nov 1;28(20):3312-3314. doi: 10.1016/j.bmcl.2018.09.017. Epub 2018 Sep 15.

23.

MRE11 inhibition highlights a replication stress-dependent vulnerability of MYCN-driven tumors.

Petroni M, Sardina F, Infante P, Bartolazzi A, Locatelli E, Fabretti F, Di Giulio S, Capalbo C, Cardinali B, Coppa A, Tessitore A, Colicchia V, Sahùn Roncero M, Belardinilli F, Di Marcotullio L, Soddu S, Comes Franchini M, Petricci E, Gulino A, Giannini G.

Cell Death Dis. 2018 Aug 30;9(9):895. doi: 10.1038/s41419-018-0924-z.

24.

The natural history of idiopathic autonomic failure: The IAF-BO cohort study.

Giannini G, Calandra-Buonaura G, Asioli GM, Cecere A, Barletta G, Mignani F, Ratti S, Guaraldi P, Provini F, Cortelli P.

Neurology. 2018 Sep 25;91(13):e1245-e1254. doi: 10.1212/WNL.0000000000006243. Epub 2018 Aug 22.

PMID:
30135257
25.

Hedgehog pathway inhibitors of the acylthiourea and acylguanidine class show antitumor activity on colon cancer in vitro and in vivo.

Vesci L, Milazzo FM, Stasi MA, Pace S, Manera F, Tallarico C, Cini E, Petricci E, Manetti F, De Santis R, Giannini G.

Eur J Med Chem. 2018 Sep 5;157:368-379. doi: 10.1016/j.ejmech.2018.07.053. Epub 2018 Jul 27.

PMID:
30099257
26.

Novel Benzazole Derivatives Endowed with Potent Antiheparanase Activity.

Madia VN, Messore A, Pescatori L, Saccoliti F, Tudino V, De Leo A, Bortolami M, Scipione L, Costi R, Rivara S, Scalvini L, Mor M, Ferrara FF, Pavoni E, Roscilli G, Cassinelli G, Milazzo FM, Battistuzzi G, Di Santo R, Giannini G.

J Med Chem. 2018 Aug 9;61(15):6918-6936. doi: 10.1021/acs.jmedchem.8b00908. Epub 2018 Jul 30.

PMID:
30010344
27.

Effective treatment of a platinum-resistant cutaneous squamous cell carcinoma case by EGFR pathway inhibition.

Capalbo C, Belardinilli F, Filetti M, Parisi C, Petroni M, Colicchia V, Tessitore A, Santoni M, Coppa A, Giannini G, Marchetti P.

Mol Clin Oncol. 2018 Jul;9(1):30-34. doi: 10.3892/mco.2018.1634. Epub 2018 May 21.

28.

Coexistence of three EGFR mutations in an NSCLC patient: A brief report.

Belardinilli F, Gradilone A, Gelibter A, Zani M, Occhipinti M, Ferraro S, Nicolazzo C, Coppa A, Giannini G.

Int J Biol Markers. 2018 Jun 1:1724600818782200. doi: 10.1177/1724600818782200. [Epub ahead of print]

PMID:
29945477
29.

Epigenetic DNA methylation changes in episodic and chronic migraine.

Terlizzi R, Bacalini MG, Pirazzini C, Giannini G, Pierangeli G, Garagnani P, Franceschi C, Cevoli S, Cortelli P.

Neurol Sci. 2018 Jun;39(Suppl 1):67-68. doi: 10.1007/s10072-018-3348-8. No abstract available.

PMID:
29904847
30.

Synthesis of Bromoundecyl Resorc[4]arenes and Applications of the Cone Stereoisomer as Selector for Liquid Chromatography.

Corradi S, Mazzoccanti G, Ghirga F, Quaglio D, Nevola L, Massera C, Ugozzoli F, Giannini G, Ciogli A, D'Acquarica I.

J Org Chem. 2018 Aug 3;83(15):7683-7693. doi: 10.1021/acs.joc.8b00488. Epub 2018 Jun 11.

PMID:
29812952
31.

Evaluation of Polygenic Determinants of Non-Alcoholic Fatty Liver Disease (NAFLD) By a Candidate Genes Resequencing Strategy.

Di Costanzo A, Belardinilli F, Bailetti D, Sponziello M, D'Erasmo L, Polimeni L, Baratta F, Pastori D, Ceci F, Montali A, Girelli G, De Masi B, Angeloni A, Giannini G, Del Ben M, Angelico F, Arca M.

Sci Rep. 2018 Feb 27;8(1):3702. doi: 10.1038/s41598-018-21939-0.

32.

Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations.

Rebbeck TR, Friebel TM, Friedman E, Hamann U, Huo D, Kwong A, Olah E, Olopade OI, Solano AR, Teo SH, Thomassen M, Weitzel JN, Chan TL, Couch FJ, Goldgar DE, Kruse TA, Palmero EI, Park SK, Torres D, van Rensburg EJ, McGuffog L, Parsons MT, Leslie G, Aalfs CM, Abugattas J, Adlard J, Agata S, Aittomäki K, Andrews L, Andrulis IL, Arason A, Arnold N, Arun BK, Asseryanis E, Auerbach L, Azzollini J, Balmaña J, Barile M, Barkardottir RB, Barrowdale D, Benitez J, Berger A, Berger R, Blanco AM, Blazer KR, Blok MJ, Bonadona V, Bonanni B, Bradbury AR, Brewer C, Buecher B, Buys SS, Caldes T, Caliebe A, Caligo MA, Campbell I, Caputo SM, Chiquette J, Chung WK, Claes KBM, Collée JM, Cook J, Davidson R, de la Hoya M, De Leeneer K, de Pauw A, Delnatte C, Diez O, Ding YC, Ditsch N, Domchek SM, Dorfling CM, Velazquez C, Dworniczak B, Eason J, Easton DF, Eeles R, Ehrencrona H, Ejlertsen B; EMBRACE, Engel C, Engert S, Evans DG, Faivre L, Feliubadaló L, Ferrer SF, Foretova L, Fowler J, Frost D, Galvão HCR, Ganz PA, Garber J, Gauthier-Villars M, Gehrig A; GEMO Study Collaborators, Gerdes AM, Gesta P, Giannini G, Giraud S, Glendon G, Godwin AK, Greene MH, Gronwald J, Gutierrez-Barrera A, Hahnen E, Hauke J; HEBON, Henderson A, Hentschel J, Hogervorst FBL, Honisch E, Imyanitov EN, Isaacs C, Izatt L, Izquierdo A, Jakubowska A, James P, Janavicius R, Jensen UB, John EM, Vijai J, Kaczmarek K, Karlan BY, Kast K, Investigators K, Kim SW, Konstantopoulou I, Korach J, Laitman Y, Lasa A, Lasset C, Lázaro C, Lee A, Lee MH, Lester J, Lesueur F, Liljegren A, Lindor NM, Longy M, Loud JT, Lu KH, Lubinski J, Machackova E, Manoukian S, Mari V, Martínez-Bouzas C, Matrai Z, Mebirouk N, Meijers-Heijboer HEJ, Meindl A, Mensenkamp AR, Mickys U, Miller A, Montagna M, Moysich KB, Mulligan AM, Musinsky J, Neuhausen SL, Nevanlinna H, Ngeow J, Nguyen HP, Niederacher D, Nielsen HR, Nielsen FC, Nussbaum RL, Offit K, Öfverholm A, Ong KR, Osorio A, Papi L, Papp J, Pasini B, Pedersen IS, Peixoto A, Peruga N, Peterlongo P, Pohl E, Pradhan N, Prajzendanc K, Prieur F, Pujol P, Radice P, Ramus SJ, Rantala J, Rashid MU, Rhiem K, Robson M, Rodriguez GC, Rogers MT, Rudaitis V, Schmidt AY, Schmutzler RK, Senter L, Shah PD, Sharma P, Side LE, Simard J, Singer CF, Skytte AB, Slavin TP, Snape K, Sobol H, Southey M, Steele L, Steinemann D, Sukiennicki G, Sutter C, Szabo CI, Tan YY, Teixeira MR, Terry MB, Teulé A, Thomas A, Thull DL, Tischkowitz M, Tognazzo S, Toland AE, Topka S, Trainer AH, Tung N, van Asperen CJ, van der Hout AH, van der Kolk LE, van der Luijt RB, Van Heetvelde M, Varesco L, Varon-Mateeva R, Vega A, Villarreal-Garza C, von Wachenfeldt A, Walker L, Wang-Gohrke S, Wappenschmidt B, Weber BHF, Yannoukakos D, Yoon SY, Zanzottera C, Zidan J, Zorn KK, Hutten Selkirk CG, Hulick PJ, Chenevix-Trench G, Spurdle AB, Antoniou AC, Nathanson KL.

Hum Mutat. 2018 May;39(5):593-620. doi: 10.1002/humu.23406. Epub 2018 Mar 12.

33.

DEVELOPING RADIATION RESISTANT THERMAL NEUTRON DETECTORS FOR THE E_LIBANS PROJECT: PRELIMINARY RESULTS.

Treccani M, Bedogni R, Pola A, Costa M, Monti V, Sans Planell O, Romano M, Durisi E, Visca DL, Bortot D, Gomez-Ros JM, Ferrero M, Anglesio S, Giannini G, Alikaniotis K.

Radiat Prot Dosimetry. 2018 Aug 1;180(1-4):304-308. doi: 10.1093/rpd/ncx298.

PMID:
29361156
34.

MEASUREMENTS OF THE PARASITIC NEUTRON DOSE AT ORGANS FROM MEDICAL LINACS AT DIFFERENT ENERGIES BY USING BUBBLE DETECTORS.

Alikaniotis K, Severgnini M, Giannini G, Milan V.

Radiat Prot Dosimetry. 2018 Aug 1;180(1-4):267-272. doi: 10.1093/rpd/ncx308.

PMID:
29361109
35.

INTENSE THERMAL NEUTRON FIELDS FROM A MEDICAL-TYPE LINAC: THE E_LIBANS PROJECT.

Costa M, Durisi E, Ferrero M, Monti V, Visca L, Anglesio S, Bedogni R, Gomez-Ros JM, Romano M, Planell OS, Treccani M, Bortot D, Pola A, Alikaniotis K, Giannini G.

Radiat Prot Dosimetry. 2018 Aug 1;180(1-4):273-277. doi: 10.1093/rpd/ncx281.

PMID:
29309701
36.

Optimizing the identification of risk-relevant mutations by multigene panel testing in selected hereditary breast/ovarian cancer families.

Coppa A, Nicolussi A, D'Inzeo S, Capalbo C, Belardinilli F, Colicchia V, Petroni M, Zani M, Ferraro S, Rinaldi C, Buffone A, Bartolazzi A, Screpanti I, Ottini L, Giannini G.

Cancer Med. 2018 Jan;7(1):46-55. doi: 10.1002/cam4.1251. Epub 2017 Dec 22.

37.

Multi-class parkinsonian disorders classification with quantitative MR markers and graph-based features using support vector machines.

Morisi R, Manners DN, Gnecco G, Lanconelli N, Testa C, Evangelisti S, Talozzi L, Gramegna LL, Bianchini C, Calandra-Buonaura G, Sambati L, Giannini G, Cortelli P, Tonon C, Lodi R.

Parkinsonism Relat Disord. 2018 Feb;47:64-70. doi: 10.1016/j.parkreldis.2017.11.343. Epub 2017 Nov 28.

PMID:
29208345
38.

Characterization of therapeutic protein AvidinOX by an integrated analytical approach.

Giannini G, Alekseeva A, Naggi A, Salvini L, Tei L, De Santis R.

Anal Bioanal Chem. 2018 Jan;410(2):553-564. doi: 10.1007/s00216-017-0754-3. Epub 2017 Nov 22.

PMID:
29167933
39.

Pancreatectomy combined with multivisceral resection for pancreatic malignancies: is it justified? Results of a systematic review.

Petrucciani N, Debs T, Nigri G, Giannini G, Sborlini E, Kassir R, Ben Amor I, Iannelli A, Valabrega S, D'Angelo F, Gugenheim J, Ramacciato G.

HPB (Oxford). 2018 Jan;20(1):3-10. doi: 10.1016/j.hpb.2017.08.002. Epub 2017 Sep 22.

40.

Arylamidonaphtalene sulfonate compounds as a novel class of heparanase inhibitors.

Rondanin R, Fochi S, Baruchello R, Bernardi T, Oliva P, Semeraro F, Simoni D, Giannini G.

Bioorg Med Chem Lett. 2017 Sep 15;27(18):4421-4425. doi: 10.1016/j.bmcl.2017.08.013. Epub 2017 Aug 8.

PMID:
28811133
41.

Inhibitory control is not lateralized in Parkinson's patients.

Mirabella G, Fragola M, Giannini G, Modugno N, Lakens D.

Neuropsychologia. 2017 Jul 28;102:177-189. doi: 10.1016/j.neuropsychologia.2017.06.025. Epub 2017 Jun 22.

PMID:
28647437
42.

A Specific Mutational Signature Associated with DNA 8-Oxoguanine Persistence in MUTYH-defective Colorectal Cancer.

Viel A, Bruselles A, Meccia E, Fornasarig M, Quaia M, Canzonieri V, Policicchio E, Urso ED, Agostini M, Genuardi M, Lucci-Cordisco E, Venesio T, Martayan A, Diodoro MG, Sanchez-Mete L, Stigliano V, Mazzei F, Grasso F, Giuliani A, Baiocchi M, Maestro R, Giannini G, Tartaglia M, Alexandrov LB, Bignami M.

EBioMedicine. 2017 Jun;20:39-49. doi: 10.1016/j.ebiom.2017.04.022. Epub 2017 Apr 13.

43.

Plasma and White Blood Cells Show Different miRNA Expression Profiles in Parkinson's Disease.

Schwienbacher C, Foco L, Picard A, Corradi E, Serafin A, Panzer J, Zanigni S, Blankenburg H, Facheris MF, Giannini G, Falla M, Cortelli P, Pramstaller PP, Hicks AA.

J Mol Neurosci. 2017 Jun;62(2):244-254. doi: 10.1007/s12031-017-0926-9. Epub 2017 May 24.

PMID:
28540642
44.

Treatment of withdrawal headache in patients with medication overuse headache: a pilot study.

Cevoli S, Giannini G, Favoni V, Terlizzi R, Sancisi E, Nicodemo M, Zanigni S, Bacchi Reggiani ML, Pierangeli G, Cortelli P.

J Headache Pain. 2017 Dec;18(1):56. doi: 10.1186/s10194-017-0763-9. Epub 2017 May 12.

45.

Obinutuzumab-mediated high-affinity ligation of FcγRIIIA/CD16 primes NK cells for IFNγ production.

Capuano C, Pighi C, Molfetta R, Paolini R, Battella S, Palmieri G, Giannini G, Belardinilli F, Santoni A, Galandrini R.

Oncoimmunology. 2017 Feb 10;6(3):e1290037. doi: 10.1080/2162402X.2017.1290037. eCollection 2017.

46.

PARP inhibitors enhance replication stress and cause mitotic catastrophe in MYCN-dependent neuroblastoma.

Colicchia V, Petroni M, Guarguaglini G, Sardina F, Sahún-Roncero M, Carbonari M, Ricci B, Heil C, Capalbo C, Belardinilli F, Coppa A, Peruzzi G, Screpanti I, Lavia P, Gulino A, Giannini G.

Oncogene. 2017 Aug 17;36(33):4682-4691. doi: 10.1038/onc.2017.40. Epub 2017 Apr 10.

PMID:
28394338
47.

The role of peroxiredoxins in cancer.

Nicolussi A, D'Inzeo S, Capalbo C, Giannini G, Coppa A.

Mol Clin Oncol. 2017 Feb;6(2):139-153. doi: 10.3892/mco.2017.1129. Epub 2017 Jan 10.

48.

White matter and cortical changes in atypical parkinsonisms: A multimodal quantitative MR study.

Zanigni S, Evangelisti S, Testa C, Manners DN, Calandra-Buonaura G, Guarino M, Gabellini A, Gramegna LL, Giannini G, Sambati L, Cortelli P, Lodi R, Tonon C.

Parkinsonism Relat Disord. 2017 Jun;39:44-51. doi: 10.1016/j.parkreldis.2017.03.001. Epub 2017 Mar 6.

PMID:
28291592
49.

The Treatment of Sleep Disorders in Parkinson's Disease: From Research to Clinical Practice.

Loddo G, Calandra-Buonaura G, Sambati L, Giannini G, Cecere A, Cortelli P, Provini F.

Front Neurol. 2017 Feb 16;8:42. doi: 10.3389/fneur.2017.00042. eCollection 2017. Review.

50.

P037. Headache in multiple sclerosis: prevalence and clinical features in a case control-study.

Terlizzi R, Merli E, Buccellato E, Giannini G, Favoni V, Pierangeli G, Salvi F, Cortelli P, Cevoli S.

J Headache Pain. 2015 Dec;16(Suppl 1):A83. doi: 10.1186/1129-2377-16-S1-A83. No abstract available.

Supplemental Content

Loading ...
Support Center